Table 1.
Case # | Somatic Mutations | Matches** | Copy Number Similarity/Rank*** |
|||
---|---|---|---|---|---|---|
Left | Right | Shared | P-Value* | |||
1 | 9 | 7 | 0 | 1.0 | −1.78 / 43 | |
2 | 3 | 3 | 0 | 1.0 | 0.76 / 20 | |
3 | 2 | 7 | 0 | 1.0 | 0.57 / 22 | |
4 | 8 | 10 | 0 | 1.0 | −1.75 / 42 | |
6 | 6 | 5 | 0 | 1.0 | 0.55/ 23 | |
8 | 6 | 2 | 1 | 0.004 | ARID1A E250fs | 3.74 / 2 |
9 | 2 | 3 | 0 | 1.0 | −1.16/ 35 | |
12 | 14 | 3 | 0 | 1.0 | −4.09 / 49 | |
13 | 3 | 3 | 0 | 1.0 | −0.22 / 28 | |
15 | 8 | 5 | 0 | 1.0 | −1.92 / 44 | |
16 | 10 | 8 | 0 | 1.0 | −2.65 / 47 | |
17 | 6 | 8 | 0 | 1.0 | −0.14/ 26 | |
18 | 8 | 2 | 0 | 1.0 | 2.37 / 5 | |
21 | 4 | 3 | 0 | 1.0 | 0.29 / 24 | |
23 | 10 | 4 | 0 | 1.0 | −1.47 / 40 | |
24 | 4 | 3 | 0 | 1.0 | 1.76/ 8 | |
25 | 4 | 6 | 0 | 1.0 | −0.32 / 30 | |
26 | 6 | 5 | 0 | 1.0 | 1.57 / 11 | |
27 | 4 | 5 | 0 | 1.0 | 1.38 / 13 | |
29 | 3 | 1 | 0 | 1.0 | −0.28 / 29 | |
30 | 6 | 5 | 0 | 1.0 | −1.18 / 36 | |
31 | 6 | 5 | 0 | 1.0 | −1.21 / 37 | |
32 | 5 | 4 | 0 | 1.0 | −0.98 / 34 | |
33 | 6 | 4 | 0 | 1.0 | 1.80 / 7 | |
35 | 5 | 4 | 0 | 1.0 | −0.01 / 25 | |
36 | 3 | 4 | 3 | <0.001 | CDH1 S111fs; TBX3 T267fs; EPPK1 R2337H | 4.46 / 1 |
38 | 8 | 2 | 0 | 1.0 | −1.60 / 41 | |
40 | 10 | 1 | 0 | 1.0 | 2.68 / 4 | |
41 | 0 | 9 | -- | 1.0 | 1.12 / 17 | |
43 | 4 | 4 | 0 | 1.0 | −0.69 / 33 | |
44 | 9 | 21 | 0 | 1.0 | −2.32 / 46 | |
45 | 3 | 4 | 0 | 1.0 | 1.24 / 15 | |
48 | 2 | 3 | 2 | <0.001 | MLH3 M346R; MAP3K1 R248* | 3.01 / 3 |
52 | 5 | 7 | 0 | 1.0 | 2.23 / 6 | |
56 | 2 | 5 | 0 | 1.0 | 1.51 / 12 | |
58 | 3 | 4 | 0 | 1.0 | −1.25 / 38 | |
59 | 2 | 3 | 0 | 1.0 | 0.83 / 19 | |
62 | 4 | 4 | 0 | 1.0 | −0.17 / 27 | |
63 | 3 | 9 | 1 | 0.08 | PIK3CA H1047R | 0.98 / 18 |
64 | 5 | 4 | 0 | 1.0 | 0.63 / 21 | |
66 | 33 | 3 | 0 | 1.0 | 1.34 / 14 | |
67 | 4 | 1 | 1 | 0.08 | PIK3CA H1047R | 1.75 / 9 |
70 | 5 | 2 | 0 | 1.0 | −2.95 / 48 | |
71 | 3 | 1 | 0 | 1.0 | 1.21 / 16 | |
72 | 1 | 3 | 0 | 1.0 | −2.19 / 45 | |
74 | 2 | 1 | 0 | 1.0 | −0.66 / 32 | |
75 | 4 | 3 | 1 | 0.08 | PIK3CA H1047R | −1.36 / 39 |
76 | 7 | 5 | 0 | 1.0 | 1.70 / 10 | |
77 | 3 | 1 | 0 | 1.0 | −0.60 / 31 |
P-value for the test of clonal relatedness of the tumor pair.
Matches were validated either by re-sampling the tumor and resequencing if sufficient tumor was available or by targeted sequencing (MiSeq), or by Sanger sequencing.
Log likelihood ratio measure of similarity of copy number profiles and ranking